David A. Siegel Repare Therapeutics Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 11,700 shares of RPTX stock, worth $37,908. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,700Holding current value
$37,908% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RPTX
# of Institutions
78Shares Held
38.5MCall Options Held
66.4KPut Options Held
2.7K-
Bvf Inc San Francisco, CA10.3MShares$33.5 Million1.46% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$10.8 Million0.35% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.12MShares$10.1 Million3.9% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$9.61 Million17.66% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.7MShares$8.76 Million0.09% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $136M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...